MATHEW ABY J. (EVP & Chief Scientific Officer) reported 1 transaction at BIOLIFE SOLUTIONS INC
Review the transaction codes below to understand the nature of each event.
Filed: 9/22/2026ACC: 0001628280-26-063078
Officer· EVP & Chief Scientific Officer
Since Mar 2026
-564.00
Net shares
Net seller
$20.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
564.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−564.00
Price / share
$36.69
Trade value
$20.69K
% of position
0.1%
9/18/2026
387.83K→387.27K
Total
Net shares
−564.00
Net value
-$20.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/18/2026 | F · Tax Withholding | −564.00 | $36.69 | $20.69K | 0.1% | 387.83K | 387.27K |
| Total | −564.00 | -$20.69K | ||||||
Derivative Transactions0
No derivative transactions reported